Berberine is often compared to GLP-1 receptor agonists in how it affects insulin sensitivity, but the mechanisms are meaningfully different
It does not diagnose symptoms, determine whether a symptom is dangerous, or recommend dose changes
While additional research is required, IGF-1 LR3 may help understand the molecular underpinnings of metabolic function in various cellular systems
The cagrilintide semaglutide mix achieves this through combined mechanisms: both peptides suppress appetite but through different brain pathways (hypothalamic GLP-1 receptors vs brainstem amylin receptors), both slow gastric emptying but through different receptor systems creating additive effects, both improve glucose control through paired mechanisms, and together provide more full body effects
Obesity phenotypes: a more targeted approach to treatment Mike Haney: Yeah
Many patients notice reduced appetite within weeks, with steady weight loss over time